Inflammatory Venous Disease Support Protocol

Cardiovascular HealthModerate Evidence
8
supplements
2
Primary
6
Supporting
2
Grade A
92
Studies

Primary Stack

Core supplements with strongest evidence
300mg standardized extract (50mg aescin) twice daily

Strengthens vein walls, reduces inflammation and capillary permeability; well-studied for venous insufficiency

20 studies2,000 participants

Venoactive flavonoids that improve venous tone, reduce inflammation, and decrease capillary leakage

25 studies3,000 participants

Supporting Stack

Additional supplements for enhanced results

Antioxidant and anti-inflammatory; strengthens capillaries and improves venous symptoms

12 studies800 participants
150mg extract twice daily

Contains ruscogenins that improve vein tone and reduce inflammation

8 studies500 participants
150-300mg daily

Oligomeric proanthocyanidins strengthen blood vessel walls and reduce inflammation

10 studies600 participants
60,000-120,000 SPU daily on empty stomach

Proteolytic enzyme with anti-inflammatory effects; may reduce swelling in venous disease

โ†“Painโ†“Superficial Thrombophlebitis Symptoms
6 studies300 participants
500-1000mg daily

Essential for collagen synthesis; supports blood vessel integrity

6 studies300 participants
2-3g EPA+DHA daily

Anti-inflammatory effects may help reduce venous inflammation

5 studies300 participants

How This Protocol Works

Simple Explanation

Inflammatory venous disease encompasses conditions where vein walls become inflamed and weakened, including chronic venous insufficiency (CVI), varicose veins, and post-thrombotic syndrome. In CVI, damaged valves in leg veins allow blood to pool, causing swelling, pain, skin changes, and potentially ulcers. Inflammation plays a key role in progression. While compression stockings and exercise are foundational, several supplements have good evidence for supporting vein health.

CRITICAL: If you have sudden leg swelling, pain, or redness, see a doctor urgently to rule out deep vein thrombosis (DVT), which is a medical emergency. Venous ulcers require medical care. These supplements support vein health but don't replace compression therapy, exercise, or medical treatment for advanced disease.

* Horse Chestnut Seed Extract (Aescin) has the strongest evidence for venous disease. Cochrane reviews confirm it reduces leg swelling, pain, and heaviness in chronic venous insufficiency. It works by strengthening vein walls and reducing capillary leakage.

* Diosmin-Hesperidin is a combination of venoactive flavonoids from citrus. It improves vein tone, reduces inflammation, and decreases capillary permeability. It is widely prescribed in Europe for venous disorders.

* Pycnogenol (Pine Bark Extract) contains proanthocyanidins that strengthen blood vessels, reduce inflammation, and improve venous symptoms.

* Butcher's Broom contains ruscogenins that have venotonic and anti-inflammatory effects. It may help reduce leg swelling and heaviness.

* Grape Seed Extract provides oligomeric proanthocyanidins that support blood vessel integrity and reduce inflammation.

* Serrapeptase is a proteolytic enzyme with anti-inflammatory effects that may help reduce swelling.

* Vitamin C is essential for collagen synthesis, which is important for vein wall structure.

* Omega-3 Fatty Acids provide anti-inflammatory effects that may help reduce venous inflammation.

Expected timeline: Horse chestnut and venoactive flavonoids: improvement in symptoms within 2-4 weeks with continued benefit over months. Compression stockings work immediately. Exercise and leg elevation help daily. These supplements work best alongside lifestyle measures.

Clinical Perspective

Inflammatory venous disease: spectrum including chronic venous insufficiency (CVI), varicose veins, superficial thrombophlebitis, post-thrombotic syndrome. CVI: affects 25-50% of adults; valve incompetence leads to venous hypertension, inflammation, leukocyte activation, capillary damage. CEAP classification: C0-C6 (C6 = active ulcer). Pathophysiology: reflux, obstruction, or calf pump failure lead to venous hypertension, inflammation, skin changes (lipodermatosclerosis), and ulceration.

CRITICAL: Rule out DVT in acute presentations (swelling, pain, warmth). CVI diagnosis: clinical exam, duplex ultrasound. Treatment hierarchy: compression (cornerstone - 20-30 mmHg minimum), exercise (calf pump), elevation, weight loss. Advanced disease: endovenous ablation, sclerotherapy, surgery. Venous ulcers require wound care and compression. Supplements are ADJUNCTIVE to compression and lifestyle.

* Horse Chestnut (Aescin) (A-grade): Reduces capillary permeability, has anti-inflammatory and venotonic effects. Cochrane review: equivalent to compression for leg pain and edema in CVI (PMID: 22786503). Meta-analysis confirms efficacy (PMID: 17440227). 300mg extract (50mg aescin) BID. GI upset possible; rare hepatotoxicity.

* Diosmin-Hesperidin (MPFF) (A-grade): Increases venous tone, reduces capillary permeability, anti-inflammatory. Meta-analysis: improves symptoms and signs of CVI (PMID: 15963285). Systematic review: effective for venous disease (PMID: 29066316). 500mg BID or 1000mg daily. Also helps hemorrhoids. Well-tolerated.

* Pycnogenol (B-grade): Proanthocyanidins strengthen capillaries, antioxidant. Review: multiple trials show benefit in CVI (PMID: 20429953). 100-200mg daily. Also helps in flight-related edema.

* Butcher's Broom (B-grade): Ruscogenins have alpha-adrenergic agonist activity, venoconstrictive. Review: improves CVI symptoms (PMID: 18254076). 150mg extract BID. Often combined with hesperidin and vitamin C.

* Grape Seed Extract (B-grade): OPCs improve endothelial function, reduce inflammation. Systematic review: reduces leg swelling in CVI (PMID: 23796756). 150-300mg daily.

* Serrapeptase (C-grade): Proteolytic enzyme; anti-edema and anti-inflammatory. Systematic review: may reduce swelling (PMID: 18272340). 60,000-120,000 SPU daily empty stomach. Limited venous-specific data.

* Vitamin C (C-grade): Essential for collagen (vessel wall structure). Review: supports vascular health (PMID: 23201831). 500-1000mg daily.

* Omega-3 Fatty Acids (C-grade): Anti-inflammatory. Review: may reduce vascular inflammation (PMID: 22541055). 2-3g EPA+DHA daily.

Biomarker targets: Clinical symptoms (pain, heaviness, swelling, cramps), leg circumference measurements, CEAP classification, quality of life scores (CIVIQ), ulcer healing rate if applicable, duplex ultrasound findings.

Protocol notes: Compression is gold standard - knee-high 20-30 mmHg for mild CVI, 30-40 mmHg for moderate-severe. Proper fitting essential. Calf muscle exercises (walking, toe raises) improve calf pump. Leg elevation above heart when possible. Weight loss reduces venous pressure. Avoid prolonged standing/sitting. For superficial thrombophlebitis: NSAIDs, compression, ambulation (DVT ruled out). Post-thrombotic syndrome prevention: adequate anticoagulation duration for DVT, compression. Venous ulcers: compression therapy, wound care, consider skin grafting. Endovenous ablation (laser, radiofrequency) or sclerotherapy for symptomatic varicose veins with reflux. Chronic anticoagulation after DVT per guidelines. Aspirin may help with ulcer healing. IPC devices for non-mobile patients. Address comorbidities (obesity, heart failure). Monitor for skin changes progression. Patient education on lifestyle crucial.